Offerings
Products
Distribution Products
- Mutual Funds
- Basket Investing
Services
- Demat Account
- 3 in 1 Account
Tools & Platforms
Platform
Tools & Calculators
- Open API
- Calculators
Markets
Stocks
F&O
Mutual Funds
ETFs
More
Research
Pricing
Resources

Sector: Pharmaceuticals & Biotechnology

Small Cap

Accretion Nutraveda Share Price

Accretion Nutraveda Ltd.

₹201.95

-3.05(-1.49%)

Trade Now

2nd Apr 2026 | 2:51 PM

NSE :

Open Free Demat Account

Accretion Nutraveda Performance

Price Movement

N/A

₹196.00

₹201.95

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹201.95

Low₹196.00

Open at₹197.05

Prev Close₹205.00

Volumes13.00 K

Avg Price₹196.61

Lower Circuit₹164.00

Upper Circuit₹246.00

Historical Performance

3M High₹229.00

3M Low₹150.10

1 Yr High₹229.00

1 Yr Low₹150.10

3 Yr High₹229.00

3 Yr Low₹150.10

5 Yr High₹229.00

5 Yr Low₹150.10

Accretion Nutraveda Fundamentals

Market Cap

Below industry Median

146.20 Cr.

PE Ratio (TTM)

High in industry

Dividend Yield

Net Profit TTM

Net profit TTM

Net Profit Growth

Net profit TTM

PEG Ratio

ROE

36% decr over last year

48.84

Operating Revenue TTM

Operating Revenue Growth

Operating Revenue TTM

Book Value

High in industry

14.40

MFI

MFI Overbought

77.27

RSI

RSI is mid-range

56.02

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

14.40

Accretion Nutraveda Financials

Data not available for chart

Indicator
No Record Found

Accretion Nutraveda Technicals

Accretion Nutraveda Ltd. EMA & SMA

₹201.95

-3.05 (-1.49%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹200.7

Day EMA10 ₹197.3

Day EMA12 ₹196.3

Day EMA20 ₹192.6

Day EMA26 ₹189.8

Accretion Nutraveda Support and Resistance

Resistance

First Resistance₹217.70

Second Resistance₹230.40

Third Resistance₹238.75

Support

First Support₹196.65

Second Support₹188.30

Third Support₹175.60

Technical Indicators

Day RSI56.02

Day MFI77.27

Day ADX11.60

Day Commodity Channel Index183.70

William-40.68

Day MACD-

Day MACD Signal Line-

Day ATR13.78

Day ROC125-

Day ROC218.93

Accretion Nutraveda Shareholding Pattern

Held By
Promoter
FII
DII
Public

Accretion Nutraveda Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	9 K	17 K	52.94%
Week	15.67 K	19 K	82.46%
1 Month	7.6 K	8.6 K	88.37%
6 Month	13.12 K	13.52 K	97.03%

Accretion Nutraveda SWOT Analysis

Strengths9

Weakness7

Opportunity0

Threats0

Relative Outperformance versus Industry over 1 Month

Annual Profit Growth higher than Sector Profit Growth

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

Accretion Nutraveda Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Accretion Nutraveda Stock Comparison

Financials	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Aptus Pharma Ltd.	Amanta Healthcare Ltd.
Price (₹)	₹37.60	₹5.80	₹89.80	₹345.05	₹108.50
% Change	1.98%	4.88%	-10.11%	-0.00%	2.54%
Revenue TTM (₹ Cr)	₹0.54	₹83.60	-	-	₹282.74
Net Profit TTM (₹ Cr)	₹-0.24	₹-34.95	-	-	₹15.30
PE TTM	-95.60	-1.40	11.90	76.40	27.40
1 Year Return	735.56	479	-29.73		-14.23
ROCE	-	-5.63	-	-	-

Similar Stocks

AHCL

Anlon Healthcare Ltd.

₹ 112.60

-0.42%

MEDISTEP

Medistep Healthcare Ltd.

₹ 17.20

+0.00%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 59.50

+2.06%

APL

Asston Pharmaceuticals Ltd.

₹ 78.00

-1.02%

INFLUX

Influx Healthtech Ltd.

₹ 214.00

+0.19%

MEDIORG

Medicamen Organics Ltd.

₹ 23.25

+4.97%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 507.95

+1.69%

ASTONEALAB

Astonea Labs Ltd.

₹ 159.60

+0.00%

AMWILL

Amwill Health Care Ltd.

₹ 31.79

+4.61%

SENORES

Senores Pharmaceuticals Ltd.

₹ 785.00

+1.48%

INNOVACAP

Innova Captab Ltd.

₹ 703.90

-0.01%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 56.10

-1.48%

SHELTER

Shelter Pharma Ltd.

₹ 29.35

-1.44%

TLL

Trident Lifeline Ltd.

₹ 263.50

-1.03%

DPL

Dipna Pharmachem Ltd.

₹ 9.00

-2.70%

ACHYUT

Achyut Healthcare Ltd.

₹ 5.65

+0.53%

FABINO

Fabino Enterprises Ltd.

₹ 16.73

+4.96%

SUPRIYA

Supriya Lifescience Ltd.

₹ 611.00

+1.66%

SIGACHI

Sigachi Industries Ltd.

₹ 19.45

-0.10%

WINDLAS

Windlas Biotech Ltd.

₹ 766.00

-0.21%

VINEETLAB

Vineet Laboratories Ltd.

₹ 29.50

+0.10%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 32.00

+0.00%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 474.80

+3.42%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.45

+2.27%

FAQ's on ANL

What is the Market Capitalization of Accretion Nutraveda Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 2 April 2026, the market cap for Accretion Nutraveda Ltd. is approximately ₹ 146.2 Cr.

What are the PE and PB ratios for Accretion Nutraveda Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Accretion Nutraveda Ltd. is 56, and the Price-to-Book (PB) ratio is 14.4.

What is the 52-Week High and Low for Accretion Nutraveda Ltd.?

Over the past 52 weeks, the highest price reached by Accretion Nutraveda Ltd. shares was ₹ 229, and the lowest price was ₹ 150.1.

Who are the major shareholders of Accretion Nutraveda Ltd.?

Significant shareholdings in Accretion Nutraveda Ltd. typically include entities such as:

Promoter
Public
Other Institutions
FII

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Accretion Nutraveda Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Accretion Nutraveda Ltd. is often compared with other major players such as Speciality Medicines, Rekvina Laboratories, Vivimed Labs, Corona Remedies and Sudeep Pharma for analysis and benchmarking.